In the search for specific targets, new compounds for candidiasis treatment has emerged in patent databases as inhibitors of Chitin synthase, Glucan synthase, Mannosyl transferase, and Secreted aspartyl proteases (SAPs) (Calugi et al., 2011). Here, SKAP2 is linked to candidiasis.